| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 99 | 2021 | 9540 | 2.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 60 | 2021 | 8648 | 1.410 |
Why?
|
| Neoplasms | 52 | 2024 | 22371 | 1.390 |
Why?
|
| Cell Line, Tumor | 82 | 2024 | 17142 | 1.240 |
Why?
|
| Genetic Heterogeneity | 7 | 2019 | 736 | 1.060 |
Why?
|
| Genome, Human | 21 | 2021 | 4446 | 1.010 |
Why?
|
| Small Molecule Libraries | 12 | 2020 | 742 | 0.960 |
Why?
|
| Mutation | 56 | 2024 | 30237 | 0.920 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2019 | 719 | 0.890 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 41 | 2022 | 3806 | 0.880 |
Why?
|
| Neoplasm Proteins | 18 | 2021 | 3604 | 0.870 |
Why?
|
| Genomics | 24 | 2022 | 5926 | 0.850 |
Why?
|
| Cell Survival | 20 | 2024 | 5789 | 0.850 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 | 2007 | 1560 | 0.820 |
Why?
|
| Leukemia, Myeloid | 9 | 2015 | 693 | 0.750 |
Why?
|
| Drug Resistance, Neoplasm | 16 | 2023 | 5341 | 0.750 |
Why?
|
| Transcription Factors | 39 | 2022 | 12171 | 0.750 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 14 | 2018 | 1437 | 0.740 |
Why?
|
| DNA Copy Number Variations | 11 | 2022 | 2048 | 0.740 |
Why?
|
| Genomic Instability | 5 | 2019 | 716 | 0.730 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 234 | 0.720 |
Why?
|
| Transcription, Genetic | 23 | 2020 | 7609 | 0.710 |
Why?
|
| Oncogene Proteins, Fusion | 14 | 2009 | 1613 | 0.680 |
Why?
|
| Organ Specificity | 4 | 2020 | 1968 | 0.660 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2024 | 3612 | 0.660 |
Why?
|
| Copper | 1 | 2022 | 368 | 0.650 |
Why?
|
| Chromosome Aberrations | 9 | 2018 | 1778 | 0.650 |
Why?
|
| Neoplasm Metastasis | 10 | 2020 | 4913 | 0.650 |
Why?
|
| Gene Expression | 20 | 2016 | 7601 | 0.650 |
Why?
|
| Translocation, Genetic | 17 | 2015 | 1394 | 0.640 |
Why?
|
| MicroRNAs | 20 | 2019 | 3803 | 0.620 |
Why?
|
| Antineoplastic Agents | 29 | 2024 | 13677 | 0.620 |
Why?
|
| Drug Repositioning | 2 | 2020 | 246 | 0.620 |
Why?
|
| DNA-Binding Proteins | 32 | 2020 | 9617 | 0.610 |
Why?
|
| Evolution, Molecular | 3 | 2019 | 1896 | 0.590 |
Why?
|
| Leukemia | 11 | 2013 | 1519 | 0.590 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2023 | 3670 | 0.590 |
Why?
|
| Oncogenes | 12 | 2019 | 1234 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 12 | 11 | 1997 | 432 | 0.570 |
Why?
|
| Repressor Proteins | 15 | 2002 | 2982 | 0.560 |
Why?
|
| Breast Neoplasms | 22 | 2023 | 21207 | 0.560 |
Why?
|
| Gene Dosage | 10 | 2017 | 1219 | 0.530 |
Why?
|
| Cell Differentiation | 33 | 2019 | 11677 | 0.520 |
Why?
|
| RNA Interference | 12 | 2023 | 2832 | 0.520 |
Why?
|
| Apoptosis | 21 | 2024 | 9527 | 0.520 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2012 | 4528 | 0.510 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 1752 | 0.510 |
Why?
|
| Gene Expression Regulation | 21 | 2018 | 11930 | 0.510 |
Why?
|
| DNA, Neoplasm | 11 | 2019 | 1744 | 0.510 |
Why?
|
| Humans | 268 | 2024 | 768171 | 0.500 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 123 | 0.490 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2014 | 2334 | 0.490 |
Why?
|
| Cell Transformation, Neoplastic | 20 | 2016 | 2846 | 0.490 |
Why?
|
| Neoplastic Stem Cells | 7 | 2022 | 1351 | 0.480 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 134 | 0.480 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2006 | 423 | 0.470 |
Why?
|
| High-Throughput Screening Assays | 6 | 2017 | 942 | 0.460 |
Why?
|
| Mice | 79 | 2024 | 82049 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2019 | 5704 | 0.440 |
Why?
|
| Genes, Neoplasm | 6 | 2018 | 371 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2008 | 387 | 0.410 |
Why?
|
| Hepatitis C, Chronic | 2 | 2013 | 1032 | 0.410 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2016 | 952 | 0.400 |
Why?
|
| Proto-Oncogene Proteins B-raf | 6 | 2019 | 2059 | 0.400 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2016 | 1339 | 0.390 |
Why?
|
| Lipoylation | 2 | 2023 | 87 | 0.390 |
Why?
|
| Liver Neoplasms | 6 | 2014 | 4363 | 0.390 |
Why?
|
| Multiple Myeloma | 3 | 2016 | 5196 | 0.390 |
Why?
|
| Animals | 90 | 2024 | 169285 | 0.380 |
Why?
|
| bcl-X Protein | 3 | 2012 | 412 | 0.380 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2018 | 368 | 0.380 |
Why?
|
| Isoquinolines | 2 | 2016 | 354 | 0.380 |
Why?
|
| Receptors, Androgen | 4 | 2006 | 1089 | 0.370 |
Why?
|
| Mitochondria | 4 | 2022 | 3683 | 0.370 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2016 | 3409 | 0.370 |
Why?
|
| DNA Mutational Analysis | 15 | 2021 | 4120 | 0.370 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2014 | 2433 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 21 | 6 | 2006 | 229 | 0.360 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.360 |
Why?
|
| Ecosystem | 1 | 2015 | 494 | 0.360 |
Why?
|
| Drug Discovery | 4 | 2018 | 1068 | 0.360 |
Why?
|
| Sequence Analysis, RNA | 6 | 2018 | 2040 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2012 | 1406 | 0.350 |
Why?
|
| Aneuploidy | 3 | 2021 | 573 | 0.350 |
Why?
|
| Quinazolines | 7 | 2014 | 1373 | 0.350 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 3948 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 4413 | 0.340 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 317 | 0.340 |
Why?
|
| Cell Proliferation | 28 | 2023 | 10478 | 0.340 |
Why?
|
| Cell Movement | 2 | 2020 | 5213 | 0.340 |
Why?
|
| Erythroid Cells | 2 | 2008 | 237 | 0.330 |
Why?
|
| Sequence Analysis, DNA | 11 | 2023 | 4786 | 0.330 |
Why?
|
| Medulloblastoma | 4 | 2024 | 683 | 0.330 |
Why?
|
| Cerebellar Neoplasms | 3 | 2024 | 591 | 0.330 |
Why?
|
| Gene Amplification | 10 | 2018 | 1095 | 0.330 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2017 | 646 | 0.320 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 3 | 2008 | 183 | 0.320 |
Why?
|
| Computational Biology | 9 | 2018 | 3567 | 0.320 |
Why?
|
| ras Proteins | 3 | 2012 | 1058 | 0.320 |
Why?
|
| Glioma | 7 | 2022 | 3503 | 0.320 |
Why?
|
| Aurintricarboxylic Acid | 1 | 2008 | 10 | 0.310 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7876 | 0.310 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 264 | 0.300 |
Why?
|
| Bone Marrow | 4 | 2016 | 2935 | 0.300 |
Why?
|
| Ribosomal Proteins | 2 | 2008 | 369 | 0.300 |
Why?
|
| Prostatic Neoplasms | 17 | 2017 | 11101 | 0.300 |
Why?
|
| Signal Transduction | 32 | 2018 | 23648 | 0.300 |
Why?
|
| Melanoma | 11 | 2013 | 5706 | 0.290 |
Why?
|
| Tumor Cells, Cultured | 20 | 2017 | 6124 | 0.290 |
Why?
|
| Histone Deacetylase Inhibitors | 5 | 2019 | 778 | 0.290 |
Why?
|
| Liver Cirrhosis | 3 | 2014 | 1960 | 0.290 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 4 | 1997 | 93 | 0.290 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1194 | 0.290 |
Why?
|
| Hematologic Neoplasms | 4 | 2024 | 1907 | 0.290 |
Why?
|
| Cell Lineage | 13 | 2017 | 2575 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-ets | 16 | 2002 | 313 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2020 | 2956 | 0.290 |
Why?
|
| Interferon-alpha | 2 | 2009 | 910 | 0.290 |
Why?
|
| Leukemia, Myeloid, Acute | 9 | 2016 | 3626 | 0.280 |
Why?
|
| Glioblastoma | 5 | 2018 | 3464 | 0.280 |
Why?
|
| Brain Neoplasms | 9 | 2022 | 9118 | 0.280 |
Why?
|
| Open Reading Frames | 4 | 2024 | 818 | 0.280 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 3728 | 0.280 |
Why?
|
| Biotechnology | 1 | 2008 | 283 | 0.270 |
Why?
|
| Models, Genetic | 9 | 2019 | 3447 | 0.270 |
Why?
|
| DNA | 5 | 2023 | 7213 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2018 | 6610 | 0.260 |
Why?
|
| Pharmaceutical Preparations | 5 | 2017 | 1088 | 0.260 |
Why?
|
| Proteomics | 6 | 2018 | 3912 | 0.260 |
Why?
|
| Cell Line | 20 | 2023 | 15602 | 0.250 |
Why?
|
| Protein Biosynthesis | 5 | 2024 | 2094 | 0.250 |
Why?
|
| Neoplasm Transplantation | 6 | 2020 | 2014 | 0.250 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 1495 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 6 | 2021 | 2830 | 0.240 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4916 | 0.240 |
Why?
|
| Cytarabine | 1 | 2007 | 695 | 0.240 |
Why?
|
| Cell Respiration | 2 | 2023 | 201 | 0.240 |
Why?
|
| Bone Neoplasms | 4 | 2014 | 2565 | 0.240 |
Why?
|
| RNA, Neoplasm | 6 | 2011 | 749 | 0.240 |
Why?
|
| Proto-Oncogenes | 5 | 2005 | 322 | 0.230 |
Why?
|
| Megakaryocytes | 2 | 2008 | 571 | 0.230 |
Why?
|
| Single-Cell Analysis | 5 | 2020 | 2540 | 0.230 |
Why?
|
| Clone Cells | 2 | 2018 | 1670 | 0.230 |
Why?
|
| Mass Spectrometry | 3 | 2018 | 2202 | 0.230 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2016 | 174 | 0.230 |
Why?
|
| Rhabdoid Tumor | 2 | 2019 | 211 | 0.230 |
Why?
|
| Species Specificity | 4 | 2017 | 2415 | 0.230 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 199 | 0.220 |
Why?
|
| Down-Regulation | 12 | 2018 | 2939 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 8 | 2012 | 355 | 0.220 |
Why?
|
| Sulfurtransferases | 1 | 2023 | 17 | 0.220 |
Why?
|
| Ferredoxins | 1 | 2023 | 9 | 0.220 |
Why?
|
| Gene Rearrangement | 9 | 2018 | 1146 | 0.220 |
Why?
|
| Hematopoiesis | 7 | 2011 | 2059 | 0.220 |
Why?
|
| Benzamides | 6 | 2019 | 1379 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 97 | 0.220 |
Why?
|
| Lymphoma, B-Cell | 6 | 2005 | 945 | 0.220 |
Why?
|
| Adenocarcinoma | 10 | 2016 | 6395 | 0.220 |
Why?
|
| Thiadiazoles | 1 | 2023 | 63 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 50 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2021 | 18065 | 0.220 |
Why?
|
| Nucleic Acid Probes | 1 | 2002 | 8 | 0.210 |
Why?
|
| Radiation Tolerance | 2 | 2016 | 476 | 0.210 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2011 | 1062 | 0.210 |
Why?
|
| Neuroblastoma | 3 | 2018 | 1266 | 0.210 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 4 | 1997 | 178 | 0.210 |
Why?
|
| Liver | 6 | 2013 | 7578 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2010 | 1810 | 0.210 |
Why?
|
| RNA, Messenger | 24 | 2013 | 12801 | 0.210 |
Why?
|
| Naphthalenes | 1 | 2023 | 198 | 0.210 |
Why?
|
| Cyclins | 2 | 2020 | 606 | 0.200 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2022 | 11 | 0.200 |
Why?
|
| Cells, Cultured | 14 | 2019 | 19025 | 0.200 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2342 | 0.200 |
Why?
|
| Cluster Analysis | 9 | 2015 | 2732 | 0.200 |
Why?
|
| Ionophores | 1 | 2022 | 108 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 12 | 2012 | 6082 | 0.200 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2022 | 73 | 0.190 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2022 | 84 | 0.190 |
Why?
|
| Prognosis | 18 | 2020 | 30009 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4648 | 0.190 |
Why?
|
| Immunologic Memory | 1 | 2008 | 1377 | 0.190 |
Why?
|
| Boronic Acids | 2 | 2016 | 915 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 581 | 0.180 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.180 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2019 | 724 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2012 | 615 | 0.180 |
Why?
|
| Phosphorylation | 12 | 2019 | 8316 | 0.180 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1904 | 0.180 |
Why?
|
| Hydrazines | 1 | 2022 | 223 | 0.170 |
Why?
|
| Semen | 1 | 2023 | 349 | 0.170 |
Why?
|
| Molecular Typing | 1 | 2020 | 115 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 800 | 0.170 |
Why?
|
| Chromosome Mapping | 6 | 2021 | 4620 | 0.170 |
Why?
|
| Databases, Factual | 3 | 2018 | 8080 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2018 | 2885 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2013 | 2892 | 0.170 |
Why?
|
| Heptanes | 1 | 2019 | 8 | 0.170 |
Why?
|
| Disulfiram | 1 | 2020 | 63 | 0.170 |
Why?
|
| Genes, BRCA1 | 2 | 2017 | 755 | 0.170 |
Why?
|
| Reproducibility of Results | 13 | 2021 | 20225 | 0.170 |
Why?
|
| Lung Neoplasms | 15 | 2016 | 13586 | 0.170 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 149 | 0.170 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2017 | 951 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2023 | 9419 | 0.160 |
Why?
|
| Proteome | 1 | 2009 | 1890 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2012 | 1246 | 0.160 |
Why?
|
| Exons | 4 | 2012 | 2394 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.160 |
Why?
|
| Female | 57 | 2024 | 397187 | 0.160 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 329 | 0.160 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2010 | 430 | 0.160 |
Why?
|
| RNA, Small Interfering | 9 | 2019 | 3428 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2009 | 658 | 0.160 |
Why?
|
| Genome | 4 | 2008 | 1754 | 0.160 |
Why?
|
| Neoplasm, Residual | 2 | 2023 | 1015 | 0.160 |
Why?
|
| Mice, Nude | 8 | 2019 | 3623 | 0.160 |
Why?
|
| Genetic Techniques | 3 | 2023 | 428 | 0.150 |
Why?
|
| Piperazines | 5 | 2019 | 2554 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 4 | 2016 | 2004 | 0.150 |
Why?
|
| Receptors, Virus | 1 | 2022 | 651 | 0.150 |
Why?
|
| Mutation, Missense | 5 | 2015 | 2592 | 0.150 |
Why?
|
| Phosphates | 1 | 2022 | 765 | 0.150 |
Why?
|
| Flow Cytometry | 12 | 2017 | 5902 | 0.150 |
Why?
|
| Cataloging | 1 | 2017 | 9 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 163 | 0.150 |
Why?
|
| Melanocytes | 4 | 2012 | 509 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2012 | 564 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2001 | 998 | 0.150 |
Why?
|
| Purines | 2 | 2020 | 615 | 0.150 |
Why?
|
| Molecular Sequence Data | 13 | 2012 | 17623 | 0.150 |
Why?
|
| HL-60 Cells | 5 | 2009 | 364 | 0.140 |
Why?
|
| Homeodomain Proteins | 6 | 2011 | 2430 | 0.140 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 215 | 0.140 |
Why?
|
| Ribosomes | 2 | 2013 | 497 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 1353 | 0.140 |
Why?
|
| Brain Stem Neoplasms | 1 | 2019 | 191 | 0.140 |
Why?
|
| Homeostasis | 3 | 2022 | 3348 | 0.140 |
Why?
|
| Cytokines | 5 | 2018 | 7452 | 0.140 |
Why?
|
| Helix-Loop-Helix Motifs | 5 | 1997 | 97 | 0.140 |
Why?
|
| Arenaviridae Infections | 1 | 2017 | 53 | 0.140 |
Why?
|
| Protein Binding | 11 | 2023 | 9343 | 0.140 |
Why?
|
| Cell Shape | 1 | 2018 | 371 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2017 | 2810 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 7 | 2017 | 5797 | 0.140 |
Why?
|
| Up-Regulation | 7 | 2018 | 4149 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2000 | 563 | 0.140 |
Why?
|
| Dipeptidases | 1 | 2016 | 38 | 0.140 |
Why?
|
| Software | 7 | 2018 | 4480 | 0.140 |
Why?
|
| Limonins | 2 | 2006 | 25 | 0.140 |
Why?
|
| Disease Progression | 10 | 2015 | 13668 | 0.140 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 1885 | 0.140 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 785 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2019 | 328 | 0.140 |
Why?
|
| Blotting, Western | 8 | 2014 | 5028 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2008 | 82 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.130 |
Why?
|
| Receptors, Estrogen | 4 | 2018 | 2253 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2009 | 3072 | 0.130 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2007 | 104 | 0.130 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2016 | 28 | 0.130 |
Why?
|
| Loss of Heterozygosity | 2 | 2016 | 663 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2017 | 165 | 0.130 |
Why?
|
| Cloning, Molecular | 3 | 1997 | 4168 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 379 | 0.130 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 4 | 2007 | 494 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2009 | 4585 | 0.130 |
Why?
|
| Neglected Diseases | 1 | 2016 | 67 | 0.130 |
Why?
|
| Caspase 1 | 1 | 2016 | 227 | 0.130 |
Why?
|
| Oncogene Proteins | 3 | 2015 | 717 | 0.130 |
Why?
|
| Pyrimidines | 6 | 2016 | 3048 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1996 | 145 | 0.130 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2015 | 24 | 0.130 |
Why?
|
| Point Mutation | 5 | 2016 | 1596 | 0.130 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 2211 | 0.130 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 18349 | 0.130 |
Why?
|
| In Situ Hybridization | 5 | 2007 | 1904 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2012 | 1074 | 0.130 |
Why?
|
| B-Lymphocytes | 2 | 2008 | 4793 | 0.120 |
Why?
|
| Plasma Cells | 2 | 2016 | 599 | 0.120 |
Why?
|
| Gene Deletion | 9 | 2016 | 2674 | 0.120 |
Why?
|
| Maltose-Binding Proteins | 1 | 2015 | 62 | 0.120 |
Why?
|
| Goals | 1 | 2021 | 717 | 0.120 |
Why?
|
| Alleles | 4 | 2022 | 6894 | 0.120 |
Why?
|
| Anemia, Diamond-Blackfan | 2 | 2008 | 147 | 0.120 |
Why?
|
| STAT Transcription Factors | 2 | 2014 | 189 | 0.120 |
Why?
|
| Microsatellite Instability | 1 | 2019 | 726 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2016 | 221 | 0.120 |
Why?
|
| 3' Untranslated Regions | 2 | 2009 | 515 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 3 | 2014 | 616 | 0.120 |
Why?
|
| Quantum Dots | 2 | 2007 | 168 | 0.120 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 129 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 3 | 2008 | 501 | 0.120 |
Why?
|
| RNA-Binding Protein EWS | 3 | 2007 | 211 | 0.120 |
Why?
|
| Sirolimus | 4 | 2006 | 1540 | 0.120 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 274 | 0.120 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2012 | 71 | 0.120 |
Why?
|
| Multigene Family | 6 | 2018 | 1081 | 0.120 |
Why?
|
| beta-Lactamases | 1 | 2017 | 307 | 0.120 |
Why?
|
| Mediastinal Neoplasms | 3 | 2015 | 403 | 0.120 |
Why?
|
| Janus Kinases | 2 | 2014 | 253 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2012 | 11878 | 0.120 |
Why?
|
| Chromosome Deletion | 5 | 2011 | 1385 | 0.120 |
Why?
|
| Male | 58 | 2023 | 364731 | 0.120 |
Why?
|
| Nuclear Proteins | 7 | 2022 | 5804 | 0.120 |
Why?
|
| Dipeptides | 1 | 2016 | 386 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 2 | 2013 | 95 | 0.120 |
Why?
|
| Mice, Inbred NOD | 6 | 2021 | 1837 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3140 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1247 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2016 | 2062 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4280 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2020 | 631 | 0.110 |
Why?
|
| Serine Proteases | 1 | 2014 | 44 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2010 | 1143 | 0.110 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2014 | 99 | 0.110 |
Why?
|
| Models, Biological | 7 | 2018 | 9497 | 0.110 |
Why?
|
| International Cooperation | 1 | 2021 | 1436 | 0.110 |
Why?
|
| Acute Disease | 6 | 2015 | 7243 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 2018 | 540 | 0.110 |
Why?
|
| Cyclin D1 | 4 | 2018 | 453 | 0.110 |
Why?
|
| Amino Acid Sequence | 6 | 2011 | 13422 | 0.110 |
Why?
|
| Systems Biology | 1 | 2017 | 482 | 0.110 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 183 | 0.110 |
Why?
|
| Cell Cycle | 4 | 2012 | 2934 | 0.110 |
Why?
|
| Models, Molecular | 6 | 2020 | 5402 | 0.110 |
Why?
|
| Histones | 5 | 2019 | 2601 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2016 | 841 | 0.110 |
Why?
|
| Drug Synergism | 4 | 2018 | 1760 | 0.110 |
Why?
|
| Lysosomes | 1 | 2019 | 938 | 0.110 |
Why?
|
| Primary Myelofibrosis | 2 | 2006 | 209 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2013 | 21 | 0.110 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 9561 | 0.110 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2007 | 290 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 478 | 0.110 |
Why?
|
| Lovastatin | 1 | 2013 | 115 | 0.110 |
Why?
|
| Cell Division | 9 | 2007 | 4477 | 0.110 |
Why?
|
| Ribonuclease III | 3 | 2010 | 271 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 186 | 0.110 |
Why?
|
| Mediator Complex | 2 | 2012 | 106 | 0.110 |
Why?
|
| NF-kappa B | 4 | 2013 | 2494 | 0.110 |
Why?
|
| Glutamates | 1 | 2014 | 385 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2012 | 637 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2016 | 2459 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 534 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2017 | 877 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2012 | 53 | 0.100 |
Why?
|
| Janus Kinase 2 | 3 | 2014 | 561 | 0.100 |
Why?
|
| Deoxycytidine | 1 | 2017 | 887 | 0.100 |
Why?
|
| Genes, Essential | 3 | 2019 | 185 | 0.100 |
Why?
|
| Carbamates | 1 | 2014 | 192 | 0.100 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 1183 | 0.100 |
Why?
|
| Predictive Value of Tests | 10 | 2015 | 15453 | 0.100 |
Why?
|
| Epithelial Cells | 9 | 2019 | 3703 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 1931 | 0.100 |
Why?
|
| Proline | 1 | 2014 | 455 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2004 | 4178 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2022 | 1884 | 0.100 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 19 | 0.100 |
Why?
|
| Transfection | 9 | 2012 | 5756 | 0.100 |
Why?
|
| Gene Library | 4 | 2018 | 1064 | 0.100 |
Why?
|
| Enzyme Activation | 7 | 2019 | 3590 | 0.100 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2012 | 56 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2014 | 393 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 1169 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2018 | 10099 | 0.100 |
Why?
|
| Genes, p53 | 2 | 2012 | 714 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2006 | 308 | 0.100 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 912 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5315 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2451 | 0.100 |
Why?
|
| K562 Cells | 3 | 2008 | 644 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 957 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2012 | 287 | 0.100 |
Why?
|
| Dioxolanes | 1 | 2011 | 23 | 0.100 |
Why?
|
| Paraffin Embedding | 2 | 2012 | 306 | 0.100 |
Why?
|
| Tissue Fixation | 2 | 2012 | 245 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2021 | 3463 | 0.090 |
Why?
|
| DNA Primers | 4 | 2006 | 2828 | 0.090 |
Why?
|
| Gene Silencing | 3 | 2017 | 1505 | 0.090 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2008 | 31 | 0.090 |
Why?
|
| Spliceosomes | 1 | 2011 | 116 | 0.090 |
Why?
|
| Base Sequence | 9 | 2020 | 12422 | 0.090 |
Why?
|
| DNA Repair | 2 | 2011 | 2050 | 0.090 |
Why?
|
| Nitriles | 2 | 2014 | 980 | 0.090 |
Why?
|
| False Positive Reactions | 2 | 2013 | 963 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 979 | 0.090 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 127 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2008 | 64 | 0.090 |
Why?
|
| YY1 Transcription Factor | 1 | 2011 | 60 | 0.090 |
Why?
|
| Response Elements | 2 | 2010 | 308 | 0.090 |
Why?
|
| Patient Participation | 1 | 2020 | 1447 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2011 | 1120 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2016 | 1906 | 0.090 |
Why?
|
| Herpesvirus 4, Human | 2 | 2007 | 1082 | 0.090 |
Why?
|
| Estrogens | 2 | 2008 | 1536 | 0.090 |
Why?
|
| Genetic Engineering | 1 | 2016 | 936 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2021 | 8741 | 0.090 |
Why?
|
| Ribonucleases | 1 | 2011 | 266 | 0.090 |
Why?
|
| Genes, Reporter | 4 | 2008 | 1524 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 337 | 0.090 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2010 | 40 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2017 | 2627 | 0.090 |
Why?
|
| Protein Array Analysis | 2 | 2019 | 399 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 108 | 0.080 |
Why?
|
| Dexamethasone | 3 | 2006 | 1965 | 0.080 |
Why?
|
| Erythroid Precursor Cells | 2 | 2008 | 211 | 0.080 |
Why?
|
| Pyridines | 2 | 2020 | 2894 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 9016 | 0.080 |
Why?
|
| Smad4 Protein | 1 | 2011 | 193 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1854 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 241 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2009 | 466 | 0.080 |
Why?
|
| Antimalarials | 1 | 2016 | 909 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 806 | 0.080 |
Why?
|
| Hodgkin Disease | 2 | 2010 | 1384 | 0.080 |
Why?
|
| Polycythemia Vera | 2 | 2005 | 160 | 0.080 |
Why?
|
| Histone Deacetylases | 3 | 2019 | 717 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 930 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 252 | 0.080 |
Why?
|
| Research Report | 1 | 2012 | 369 | 0.080 |
Why?
|
| Indoles | 3 | 2012 | 1836 | 0.080 |
Why?
|
| Ectoderm | 1 | 2009 | 138 | 0.080 |
Why?
|
| Macrophages | 5 | 2017 | 5802 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 22380 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2009 | 272 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2009 | 102 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 628 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 2931 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2909 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 729 | 0.080 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 136 | 0.080 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 928 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2014 | 1194 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 911 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2008 | 48 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2012 | 1767 | 0.080 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 51 | 0.080 |
Why?
|
| Antigens, CD34 | 2 | 2008 | 657 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2010 | 231 | 0.080 |
Why?
|
| Cell Cycle Proteins | 5 | 2015 | 3445 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1344 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2008 | 410 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 572 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 2005 | 71 | 0.080 |
Why?
|
| Mammals | 2 | 2022 | 1135 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 519 | 0.080 |
Why?
|
| GATA4 Transcription Factor | 1 | 2009 | 125 | 0.080 |
Why?
|
| Methylation | 1 | 2011 | 1078 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2017 | 858 | 0.080 |
Why?
|
| Immunoblotting | 5 | 2017 | 1648 | 0.070 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2008 | 54 | 0.070 |
Why?
|
| Germinal Center | 1 | 2011 | 380 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 2568 | 0.070 |
Why?
|
| Retinoids | 1 | 2008 | 99 | 0.070 |
Why?
|
| Histone Code | 2 | 2019 | 160 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2014 | 1247 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 130 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 3056 | 0.070 |
Why?
|
| Androgens | 2 | 2006 | 1281 | 0.070 |
Why?
|
| Integrin beta3 | 1 | 2008 | 120 | 0.070 |
Why?
|
| Phenotype | 7 | 2016 | 16726 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1623 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2023 | 4754 | 0.070 |
Why?
|
| Internet | 2 | 2017 | 3110 | 0.070 |
Why?
|
| Microspheres | 2 | 2009 | 788 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 255 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 171 | 0.070 |
Why?
|
| Molecular Probes | 1 | 2009 | 309 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2015 | 3956 | 0.070 |
Why?
|
| Genotype | 5 | 2016 | 13045 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 385 | 0.070 |
Why?
|
| Fluorometry | 1 | 2007 | 99 | 0.070 |
Why?
|
| E2F Transcription Factors | 3 | 2017 | 270 | 0.070 |
Why?
|
| Metribolone | 1 | 2006 | 13 | 0.070 |
Why?
|
| Consensus Sequence | 1 | 2007 | 363 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2666 | 0.070 |
Why?
|
| Neuroendocrine Tumors | 2 | 2013 | 657 | 0.070 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2006 | 36 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 227 | 0.070 |
Why?
|
| Phenothiazines | 1 | 2006 | 60 | 0.070 |
Why?
|
| RNA Precursors | 1 | 2008 | 196 | 0.070 |
Why?
|
| Granulocytes | 3 | 2006 | 551 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2012 | 1337 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2024 | 6231 | 0.070 |
Why?
|
| Retroviridae | 3 | 2006 | 846 | 0.070 |
Why?
|
| Databases, Genetic | 4 | 2017 | 1758 | 0.070 |
Why?
|
| Malaria | 1 | 2016 | 1249 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2222 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2009 | 3074 | 0.070 |
Why?
|
| Algorithms | 11 | 2018 | 14164 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2629 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 3 | 2023 | 2907 | 0.070 |
Why?
|
| Staurosporine | 2 | 2007 | 241 | 0.070 |
Why?
|
| Erythropoietin | 2 | 2008 | 718 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2020 | 663 | 0.070 |
Why?
|
| CpG Islands | 1 | 2011 | 1208 | 0.070 |
Why?
|
| Triterpenes | 1 | 2006 | 78 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2018 | 3591 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 1756 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5442 | 0.070 |
Why?
|
| Thrombopoietin | 1 | 2008 | 225 | 0.070 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2006 | 49 | 0.070 |
Why?
|
| Protein Kinases | 4 | 2009 | 1611 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2009 | 591 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2008 | 539 | 0.060 |
Why?
|
| Endoderm | 1 | 2007 | 165 | 0.060 |
Why?
|
| Benzoquinones | 1 | 2006 | 198 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2152 | 0.060 |
Why?
|
| Molecular Weight | 2 | 2007 | 2173 | 0.060 |
Why?
|
| Chromatin | 5 | 2019 | 2981 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2603 | 0.060 |
Why?
|
| Blotting, Northern | 4 | 2002 | 1553 | 0.060 |
Why?
|
| Sulfonamides | 2 | 2012 | 1982 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 2414 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2009 | 725 | 0.060 |
Why?
|
| Prostate | 4 | 2011 | 1765 | 0.060 |
Why?
|
| Treatment Outcome | 11 | 2018 | 65379 | 0.060 |
Why?
|
| Proteins | 6 | 2009 | 6009 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2006 | 1305 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2179 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 686 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 10763 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2007 | 210 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2014 | 5432 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1162 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 319 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 561 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 12795 | 0.060 |
Why?
|
| Karyotyping | 3 | 1997 | 1177 | 0.060 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 111 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2024 | 14729 | 0.060 |
Why?
|
| Child | 14 | 2022 | 80917 | 0.060 |
Why?
|
| Viral Matrix Proteins | 1 | 2005 | 193 | 0.060 |
Why?
|
| Cyclin A | 1 | 2004 | 60 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 1047 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2014 | 1628 | 0.060 |
Why?
|
| Classification | 1 | 2004 | 128 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 691 | 0.060 |
Why?
|
| Cisplatin | 1 | 2010 | 1660 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 114 | 0.060 |
Why?
|
| Middle Aged | 19 | 2020 | 223487 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2015 | 2521 | 0.050 |
Why?
|
| Cell Nucleus | 5 | 2008 | 2885 | 0.050 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2002 | 168 | 0.050 |
Why?
|
| Genes, ras | 3 | 2012 | 663 | 0.050 |
Why?
|
| Ligands | 3 | 2018 | 3284 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1606 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 102 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2000 | 3097 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2015 | 4058 | 0.050 |
Why?
|
| Time Factors | 7 | 2021 | 40220 | 0.050 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2003 | 81 | 0.050 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 633 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2020 | 5107 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 665 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 288 | 0.050 |
Why?
|
| Adult | 20 | 2023 | 223646 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 3 | 2011 | 351 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2008 | 1399 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2000 | 1327 | 0.050 |
Why?
|
| Interferons | 2 | 2023 | 720 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 1951 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 681 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 1668 | 0.050 |
Why?
|
| Nasopharynx | 1 | 2005 | 420 | 0.050 |
Why?
|
| Thalidomide | 1 | 2008 | 886 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2014 | 205 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2002 | 251 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1997 | 2748 | 0.050 |
Why?
|
| Disease | 1 | 2007 | 675 | 0.050 |
Why?
|
| Tetracyclines | 1 | 2002 | 64 | 0.050 |
Why?
|
| Dimerization | 2 | 2010 | 887 | 0.050 |
Why?
|
| Starvation | 1 | 2002 | 141 | 0.050 |
Why?
|
| DNA Methylation | 4 | 2019 | 4428 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 620 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2015 | 3740 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1743 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2009 | 1344 | 0.050 |
Why?
|
| Chromosome Breakpoints | 2 | 2012 | 93 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2010 | 4035 | 0.050 |
Why?
|
| Lymphoma | 1 | 2011 | 1898 | 0.050 |
Why?
|
| Syndrome | 1 | 2008 | 3273 | 0.050 |
Why?
|
| Aged | 16 | 2020 | 171502 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2359 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2021 | 317 | 0.050 |
Why?
|
| Thiazoles | 1 | 2008 | 1542 | 0.050 |
Why?
|
| RNA Splicing | 2 | 2019 | 905 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2011 | 1893 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4355 | 0.050 |
Why?
|
| Diploidy | 1 | 2021 | 140 | 0.040 |
Why?
|
| Ligases | 1 | 2002 | 333 | 0.040 |
Why?
|
| GAP-43 Protein | 1 | 2000 | 152 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2021 | 224 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2014 | 260 | 0.040 |
Why?
|
| Colorectal Neoplasms | 2 | 2012 | 6975 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1642 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 1997 | 775 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1891 | 0.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2002 | 249 | 0.040 |
Why?
|
| Sample Size | 2 | 2014 | 846 | 0.040 |
Why?
|
| Iron | 1 | 2008 | 1813 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 123 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 693 | 0.040 |
Why?
|
| Fixatives | 2 | 2012 | 90 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 434 | 0.040 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2332 | 0.040 |
Why?
|
| Glucocorticoids | 2 | 2006 | 2167 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1536 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2021 | 230 | 0.040 |
Why?
|
| Sequence Deletion | 4 | 2011 | 1497 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1250 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 31 | 0.040 |
Why?
|
| raf Kinases | 2 | 2011 | 117 | 0.040 |
Why?
|
| Carrier Proteins | 4 | 2011 | 4939 | 0.040 |
Why?
|
| Oligonucleotide Probes | 3 | 2007 | 417 | 0.040 |
Why?
|
| Vincristine | 1 | 2002 | 1040 | 0.040 |
Why?
|
| DNA Damage | 3 | 2016 | 2469 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6512 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2011 | 2401 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2000 | 238 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 3 | 2013 | 3620 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 1667 | 0.040 |
Why?
|
| Tretinoin | 1 | 2002 | 525 | 0.040 |
Why?
|
| Transcription Factors, TFII | 1 | 1998 | 62 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 279 | 0.040 |
Why?
|
| Child, Preschool | 9 | 2015 | 42669 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2005 | 701 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3251 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 2008 | 1989 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 1769 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39354 | 0.040 |
Why?
|
| Immunohistochemistry | 6 | 2015 | 11095 | 0.040 |
Why?
|
| Sarcoma | 1 | 2009 | 1806 | 0.040 |
Why?
|
| Pons | 1 | 2019 | 242 | 0.040 |
Why?
|
| Formaldehyde | 2 | 2012 | 361 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2019 | 41753 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 1966 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2018 | 97 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2005 | 2857 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Cervix Uteri | 3 | 1991 | 577 | 0.040 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 3 | 2005 | 257 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 386 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2020 | 293 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 373 | 0.040 |
Why?
|
| Genome, Fungal | 1 | 1998 | 203 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 189 | 0.040 |
Why?
|
| Oocytes | 1 | 2002 | 1172 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2018 | 2089 | 0.040 |
Why?
|
| Genes, Viral | 2 | 2005 | 655 | 0.040 |
Why?
|
| Survival Rate | 5 | 2020 | 12840 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 1999 | 740 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 392 | 0.040 |
Why?
|
| Yolk Sac | 1 | 1997 | 79 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 16044 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 854 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2018 | 196 | 0.040 |
Why?
|
| Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 239 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 548 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1240 | 0.030 |
Why?
|
| Infant | 7 | 2015 | 36535 | 0.030 |
Why?
|
| Oxygen | 1 | 2008 | 4270 | 0.030 |
Why?
|
| Prednisone | 1 | 2002 | 1567 | 0.030 |
Why?
|
| Carboxy-Lyases | 1 | 2017 | 85 | 0.030 |
Why?
|
| Genes, abl | 1 | 1997 | 69 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 131 | 0.030 |
Why?
|
| Leukemia, B-Cell | 1 | 1997 | 86 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 378 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3772 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1165 | 0.030 |
Why?
|
| Papillomaviridae | 3 | 2011 | 1140 | 0.030 |
Why?
|
| Life Tables | 1 | 1996 | 367 | 0.030 |
Why?
|
| Interleukin-3 | 3 | 2005 | 425 | 0.030 |
Why?
|
| Cells | 1 | 2017 | 166 | 0.030 |
Why?
|
| Thionucleosides | 1 | 2016 | 13 | 0.030 |
Why?
|
| Hematopoietic System | 1 | 1996 | 110 | 0.030 |
Why?
|
| Deoxyadenosines | 1 | 2016 | 27 | 0.030 |
Why?
|
| Pharmacogenetics | 2 | 2012 | 683 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 176 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 59626 | 0.030 |
Why?
|
| Metabolome | 1 | 2023 | 1009 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2016 | 56 | 0.030 |
Why?
|
| Amino Acids | 1 | 2002 | 1716 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1998 | 497 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2001 | 802 | 0.030 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3833 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2227 | 0.030 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 1995 | 17 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2002 | 1676 | 0.030 |
Why?
|
| U937 Cells | 2 | 2009 | 260 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 594 | 0.030 |
Why?
|
| Autopsy | 1 | 2019 | 1011 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2237 | 0.030 |
Why?
|
| Apoproteins | 1 | 2015 | 45 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2020 | 1009 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 905 | 0.030 |
Why?
|
| Serine | 1 | 2019 | 831 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2016 | 540 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 354 | 0.030 |
Why?
|
| Homozygote | 2 | 2014 | 1779 | 0.030 |
Why?
|
| Protein Folding | 1 | 2019 | 871 | 0.030 |
Why?
|
| Mutant Proteins | 2 | 2007 | 488 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 2014 | 17 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2014 | 1890 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2000 | 1179 | 0.030 |
Why?
|
| Adipocytes | 1 | 2002 | 1199 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2001 | 2923 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 393 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12077 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2006 | 3403 | 0.030 |
Why?
|
| Testosterone | 1 | 2006 | 2491 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2002 | 2234 | 0.030 |
Why?
|
| Pyridones | 1 | 2020 | 819 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1997 | 338 | 0.030 |
Why?
|
| Kinetics | 1 | 2022 | 6330 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1361 | 0.030 |
Why?
|
| Mucin-1 | 1 | 2019 | 537 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 565 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 45 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 606 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2007 | 2819 | 0.030 |
Why?
|
| Luciferases | 2 | 2007 | 713 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 1998 | 549 | 0.030 |
Why?
|
| National Health Programs | 1 | 2017 | 442 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 996 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 593 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 520 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3161 | 0.030 |
Why?
|
| Biopsy | 3 | 2015 | 6792 | 0.030 |
Why?
|
| Receptor, trkB | 1 | 2014 | 124 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 794 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2007 | 435 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2014 | 22290 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 948 | 0.030 |
Why?
|
| Glucose | 2 | 2003 | 4352 | 0.030 |
Why?
|
| Receptor, trkA | 1 | 2014 | 159 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1319 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1300 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 1525 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 213 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2015 | 390 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 569 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2015 | 699 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 806 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 117 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 446 | 0.030 |
Why?
|
| Calreticulin | 1 | 2014 | 115 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 1812 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 6209 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 4206 | 0.030 |
Why?
|
| Benzofurans | 1 | 2013 | 139 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2064 | 0.030 |
Why?
|
| Myeloid Cells | 2 | 2009 | 839 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 6847 | 0.030 |
Why?
|
| Bile Ducts | 1 | 2014 | 288 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 42 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 126 | 0.030 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2012 | 19 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1143 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2017 | 843 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1230 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2393 | 0.020 |
Why?
|
| Probability | 2 | 2007 | 2479 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2012 | 159 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2017 | 830 | 0.020 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14488 | 0.020 |
Why?
|
| SOS1 Protein | 1 | 2011 | 40 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 622 | 0.020 |
Why?
|
| Insulin Resistance | 2 | 2002 | 3986 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2023 | 54924 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 669 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1998 | 3623 | 0.020 |
Why?
|
| Comet Assay | 1 | 2011 | 74 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 2010 | 5863 | 0.020 |
Why?
|
| Vietnam | 1 | 2012 | 415 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2012 | 223 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 4978 | 0.020 |
Why?
|
| Coumarins | 1 | 2011 | 119 | 0.020 |
Why?
|
| Adolescent | 8 | 2015 | 89169 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 321 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 547 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6229 | 0.020 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 122 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 410 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3655 | 0.020 |
Why?
|
| Neuroglia | 1 | 2016 | 960 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 348 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 411 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2010 | 33 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 202 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 630 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 72 | 0.020 |
Why?
|
| Immune Evasion | 1 | 2014 | 375 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1673 | 0.020 |
Why?
|
| Rats | 4 | 2014 | 23782 | 0.020 |
Why?
|
| Neurofibromin 1 | 1 | 2011 | 190 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2012 | 577 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 1997 | 1370 | 0.020 |
Why?
|
| Tyrosine | 2 | 2009 | 1427 | 0.020 |
Why?
|
| Mitosis | 2 | 2005 | 1178 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 438 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2003 | 13013 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3814 | 0.020 |
Why?
|
| Drug Design | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 769 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 836 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 221 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3713 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 133 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 384 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1996 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 1412 | 0.020 |
Why?
|
| Indole Alkaloids | 1 | 2009 | 23 | 0.020 |
Why?
|
| Immunophilins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Gene Fusion | 1 | 2012 | 356 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 200 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 426 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 1839 | 0.020 |
Why?
|
| United States | 4 | 2020 | 73039 | 0.020 |
Why?
|
| Interleukins | 1 | 2014 | 796 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 895 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2410 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 710 | 0.020 |
Why?
|
| Penetrance | 1 | 2011 | 385 | 0.020 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2008 | 30 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 672 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 311 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 457 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2843 | 0.020 |
Why?
|
| Core Binding Factors | 1 | 2008 | 29 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 474 | 0.020 |
Why?
|
| Financing, Government | 1 | 2012 | 473 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 757 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26421 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2100 | 0.020 |
Why?
|
| Epithelium | 3 | 2006 | 1607 | 0.020 |
Why?
|
| Spleen | 2 | 2006 | 2296 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 696 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2682 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1228 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1376 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2008 | 225 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 241 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 725 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8542 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1375 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1151 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 141 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1407 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 180 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 394 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 106 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1887 | 0.020 |
Why?
|
| Carcinogenicity Tests | 1 | 2007 | 39 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 521 | 0.020 |
Why?
|
| Oxazines | 1 | 2009 | 358 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2661 | 0.020 |
Why?
|
| Carbazoles | 1 | 2009 | 230 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 275 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 300 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1086 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 10101 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 2012 | 596 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4861 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 1001 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2009 | 562 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1103 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 71 | 0.020 |
Why?
|
| Protein Stability | 1 | 2008 | 579 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 11244 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2006 | 38 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 320 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 1191 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2744 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3556 | 0.020 |
Why?
|
| Binding Sites | 2 | 2008 | 6019 | 0.020 |
Why?
|
| Viscera | 1 | 2007 | 138 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2006 | 30 | 0.020 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2006 | 34 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1563 | 0.020 |
Why?
|
| Morpholines | 1 | 2009 | 584 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2631 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1056 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 662 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1832 | 0.020 |
Why?
|
| Blastocyst | 1 | 2009 | 433 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1680 | 0.020 |
Why?
|
| Stem Cells | 3 | 2005 | 3538 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2006 | 88 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2007 | 2709 | 0.020 |
Why?
|
| Diphenylamine | 1 | 2005 | 49 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 105 | 0.020 |
Why?
|
| Calcium | 2 | 2017 | 5792 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2747 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1625 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 3214 | 0.020 |
Why?
|
| Microdissection | 1 | 2006 | 150 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 846 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2009 | 580 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Keratinocytes | 1 | 1990 | 876 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2541 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 440 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1715 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 201 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4939 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8052 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2004 | 21 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 640 | 0.020 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2004 | 37 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 458 | 0.020 |
Why?
|
| Sweden | 1 | 2008 | 1382 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 8759 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 1996 | 317 | 0.010 |
Why?
|
| GATA1 Transcription Factor | 1 | 2006 | 306 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 482 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 2005 | 194 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1216 | 0.010 |
Why?
|
| Immunophenotyping | 2 | 2001 | 1864 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2005 | 147 | 0.010 |
Why?
|
| Cyclin A1 | 1 | 2004 | 11 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1613 | 0.010 |
Why?
|
| Artifacts | 1 | 2013 | 1926 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 185 | 0.010 |
Why?
|
| G1 Phase | 1 | 2005 | 403 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.010 |
Why?
|
| Phenols | 1 | 2008 | 526 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 13091 | 0.010 |
Why?
|
| Cholesterol | 1 | 2013 | 2914 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2008 | 1643 | 0.010 |
Why?
|
| Insulin | 3 | 2003 | 6610 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7064 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2003 | 48 | 0.010 |
Why?
|
| Mesoderm | 1 | 2007 | 679 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 866 | 0.010 |
Why?
|
| S Phase | 1 | 2004 | 424 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 447 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7477 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 816 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 103 | 0.010 |
Why?
|
| Animals, Congenic | 1 | 2002 | 27 | 0.010 |
Why?
|
| Pyrroles | 1 | 2009 | 1124 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 753 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1197 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 611 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1657 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 1027 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 2914 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 104 | 0.010 |
Why?
|
| RNA | 2 | 2003 | 2722 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2002 | 216 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1754 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2007 | 995 | 0.010 |
Why?
|
| Osteopetrosis | 1 | 2002 | 42 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 872 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5151 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 809 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 437 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 188 | 0.010 |
Why?
|
| Microtubules | 1 | 2008 | 1064 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2907 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 234 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 203 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2002 | 341 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 343 | 0.010 |
Why?
|
| Neurons | 2 | 2017 | 9514 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 910 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 432 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 81760 | 0.010 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2002 | 85 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2002 | 241 | 0.010 |
Why?
|
| Metalloproteins | 1 | 2002 | 98 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1162 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 138 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 136 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2603 | 0.010 |
Why?
|
| Lasers | 1 | 2006 | 952 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2002 | 271 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 2463 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 390 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1991 | 2043 | 0.010 |
Why?
|
| Enzymes | 1 | 2002 | 254 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 394 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2065 | 0.010 |
Why?
|
| Estradiol | 1 | 2008 | 1951 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 564 | 0.010 |
Why?
|
| Thymosin | 1 | 2000 | 47 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2001 | 289 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1084 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 437 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2007 | 617 | 0.010 |
Why?
|
| Smoking | 2 | 2011 | 9092 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3628 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 627 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 317 | 0.010 |
Why?
|
| Bradykinin | 1 | 2000 | 205 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 3845 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1682 | 0.010 |
Why?
|
| Placebos | 1 | 2004 | 1667 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1016 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2006 | 1019 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2002 | 517 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 751 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 525 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2057 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 419 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2000 | 280 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 1640 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1135 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 235 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 12252 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 1998 | 49 | 0.010 |
Why?
|
| Immunity | 1 | 2004 | 1003 | 0.010 |
Why?
|
| Genes, cdc | 1 | 1998 | 113 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2002 | 713 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 2423 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1998 | 150 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 2709 | 0.010 |
Why?
|
| Neurites | 1 | 2000 | 389 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1207 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2798 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4057 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1093 | 0.010 |
Why?
|
| Piperidines | 1 | 2006 | 1667 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10397 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2006 | 1786 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2230 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 2000 | 407 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2862 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 2028 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 1998 | 231 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 1998 | 192 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1617 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2006 | 919 | 0.010 |
Why?
|
| Chimera | 1 | 1998 | 454 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2003 | 1157 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1998 | 445 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1996 | 175 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 101 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 722 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2002 | 1153 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 1998 | 335 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 420 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1728 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2000 | 490 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9613 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1750 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 325 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3589 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1207 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 542 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1998 | 906 | 0.010 |
Why?
|
| Nerve Regeneration | 1 | 2000 | 797 | 0.010 |
Why?
|
| Zebrafish | 1 | 2005 | 3035 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2819 | 0.010 |
Why?
|
| Placenta | 1 | 2002 | 1725 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 60066 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1995 | 498 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 849 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2002 | 3334 | 0.010 |
Why?
|
| Physicians | 1 | 2008 | 4598 | 0.010 |
Why?
|
| Desmosomes | 1 | 1989 | 73 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 1367 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2003 | 6283 | 0.010 |
Why?
|
| Neutrophils | 1 | 2001 | 3786 | 0.000 |
Why?
|
| Keratins | 1 | 1989 | 499 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1989 | 406 | 0.000 |
Why?
|
| Hippocampus | 1 | 2000 | 3783 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3610 | 0.000 |
Why?
|
| Culture Media | 1 | 1989 | 898 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8509 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 2560 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1990 | 1080 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2269 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2474 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10266 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1505 | 0.000 |
Why?
|
| Heart Failure | 1 | 2009 | 11879 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5717 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1989 | 1133 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 2204 | 0.000 |
Why?
|
| Pregnancy | 2 | 1998 | 30255 | 0.000 |
Why?
|
| Fetus | 1 | 1990 | 1883 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21538 | 0.000 |
Why?
|
| Skin | 1 | 1990 | 4505 | 0.000 |
Why?
|
| Risk Factors | 1 | 2002 | 74944 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9262 | 0.000 |
Why?
|